Bruce Hollis to Parathyroid Hormone-Related Protein
This is a "connection" page, showing publications Bruce Hollis has written about Parathyroid Hormone-Related Protein.
Connection Strength
0.402
-
A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover. J Bone Miner Res. 2011 Sep; 26(9):2287-97.
Score: 0.098
-
Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose. J Clin Endocrinol Metab. 2010 Mar; 95(3):1279-87.
Score: 0.087
-
Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation study. Osteoporos Int. 2006 Feb; 17(2):225-30.
Score: 0.065
-
Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. J Bone Miner Res. 2005 Oct; 20(10):1792-803.
Score: 0.064
-
Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab. 2003 Apr; 88(4):1603-9.
Score: 0.055
-
Parathyroid hormone-related peptide content of bovine milk and calf blood assessed by radioimmunoassay and bioassay. Endocrinology. 1991 Dec; 129(6):2815-9.
Score: 0.025
-
Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA. 1996 Aug 21; 276(7):549-54.
Score: 0.009